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Malignant  ﬁbrous  histiocytoma  is a sarcoma  which  commonly  occurs  in the  soft  tissues,  joints  and  ten-
dons  of  the  extremities  of  adults  but its  occurrence  in  the  oral  and  maxillofacial  region  is very  rare.  We
present  a  rare  case  of malignant  ﬁbrous  histiocytoma  of  the  mandible  with  recurrence  in  the  infratempo-ccepted 27 March 2011
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ral  fossa  after  surgery  and  radiotherapy.  Patient  underwent  second  surgery  and  complete  tumor  excision
with  minimal  loss  of function  was  achieved.  Patient  survived  8  years  after  surgery  and  died  of  natural
cause.
© 2011 Surgical Associates Ltd. Elsevier Ltd. Open access under CC BY-NC-ND license.nfratemporal fossa
. Introduction
Malignant ﬁbrous histiocytoma is the most common soft tis-
ue sarcoma affecting people in late adult life. It originates from
he deep fascia and skeletal muscles and commonly involves the
xtremities especially the lower limb.1,2 Its occurrence in the oral
nd maxillofacial region, however, is extremely rare. Only 30 cases
ave been reported till date in the head and neck region.
In  this article we report a rare case of malignant ﬁbrous his-
iocytoma of the mandible with recurrence in the infratemporal
ossa.
. Case history
A  66-year-old male patient presented with the chief complaint
f swelling over the left side of face for 1 month. There was
o associated pain, trismus or facial weakness. There was a his-
ory of similar swelling 5 years back. Review of clinical notes
equested from another institution, where patient had undergone
nitial treatment, showed that a 3 cm × 5 cm lesion involving left
ower gingivobuccal sulcus and adjacent mandible at the level of
olars was seen. The mucosa over the lesion was not ulcerated.
ide local excision and hemimandibulectomy was done without
econstruction and was followed by radiotherapy.
On examination a hard, ill-deﬁned, smooth surfaced, ﬁxed massas seen below the zygomatic arch on left side. The skin over the
welling was not clinically involved by the tumor. A 1 cm × 2 cm
lcerative lesion was seen in the posterior part of left buccal mucosa
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Open access under CC BY-NC-ND liceadjacent to the last upper molar tooth. The upper gingivobuccal sul-
cus was free of tumor. Organ-speciﬁc examination was  done to rule
out any metastatic disease with special attention to the respiratory
system, the central nervous system and the abdomen. There were
no clinical signs suggestive of systemic metastasis. All hematolog-
ical and biochemical parameters were within normal range.
A  ﬁne needle aspiration cytology was performed. It showed
atypical spindle and pleomorphic cells suggestive of a sarcoma.
Incisional biopsy from the buccal lesion was  inconclusive. A chest
X-ray was done which ruled out any lung metastasis.
A CT scan was done to assess the extent and nature of tumor. It
showed a 3 cm × 4 cm lobulated tumor in the infratemporal fossa
with areas of hyperdensity eroding postero-lateral wall of the left
maxillary antrum (Figs. 1–3). No cranial extension of the tumor was
seen on CT scan. Because of the high cost and limited availability,
an MRI  could not be justiﬁed in this situation.
2.1. Surgical technique
To  ensure good access to the tumor and wide exposure, an inci-
sion was made at the nasofacial junction as in lateral rhinotomy.
It was  extended laterally as subciliary incision towards the pinna,
then extended inferiorly towards the preauricular area and superi-
orly to the temporal area (Fig. 4). The maxillary antrum was  opened
and inspected. Even though the posterolateral bony wall was
eroded, the tumor did not extend into the maxillary antrum. The
zygomatic arch was divided and tumor in the infratemporal fossa
along with the pterygoid muscle was  removed by subperiosteal dis-
section along the skull base. The facial nerve was engulfed by the
tumor so it was  sacriﬁced. The tumor was  removed with the lat-
eral pterygoid plate. Thinned out bone and attached mucosa of the
nse.
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Fig. 1. Axial CT image - showing a soft tissue mass in the left infratemporal fossa
eroding posterior-lateral wall of the maxillary antrum.
Fig. 2. Coronal CT image–showing a lobulated well-deﬁned soft tissue mass extend-
ing  from the infratemporal fossa to involve the soft tissue of the left cheek.
Fig. 3. Axial CT image showing mass in the left infratemporal fossa.
Fig. 4. Planned surgical approach and incision.
Fig. 5. Histopathology showing storiform pattern.posterior wall of maxilla as well as hard ﬁbrous tissue in the retro-
molar area was sent for frozen section and was reported as negative.
Residual defect in the posterior wall of the maxillary antrum
was repaired with temporalis fascia and the temporalis muscle was
rotated inferiorly to obliterate the infratemporal fossa. Abdominal
fat was used to augment the temporal fossa. Post operatively, the
ﬂap was  healthy and patient recovered well.Histopathology revealed the tumor to be malignant ﬁbrous his-
tiocytoma of storiform-variety (Fig. 5).
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The patient had already received maximum radiation dose to
he head and neck region after his ﬁrst surgery and therefore could
ot be offered any further radiation to the region.
On follow up patient was healthy and there was no recurrence
f tumor. Patient survived 8 years after surgery and died of natural
ause.
. Discussion
Malignant ﬁbrous histocytoma commonly arises from the soft
issues, tendons, bones and joints of upper and lower limbs of
dults.3–6 Males are affected more commonly than females with
eak incidence in the sixth decade of life.7 70% of these tumors
re primary tumors while the other 30% are associated with pre-
xisting conditions such as prior radiation therapy to the region.8
Only 3–10% MFH  occur in the head and neck region and most of
hese are located in the sinonasal tract.9,10 The occurrence of MFH
n membranous bones including the mandible is quite unusual.9 In
he present case, primary was in the mandible and recurrence was
een in the infratemporal fossa.
MFH typically appears as a nonspeciﬁc, large, lobulated, soft
issue mass of predominantly muscle density, with nodular and
eripheral enhancement of solid portions on CT scan. Central
reas of low attenuation may  be present, corresponding to myx-
id regions, old hemorrhage, or necrosis. Fat attenuation is usually
ot observed in the tumors, which can distinguish this tumor from
ome well-differentiated liposarcomas. Calciﬁcation or ossiﬁcation
an be detected in 5–20% of the patients. Heterotopic bone for-
ation may  be present in the periphery of the mass.11,12 In the
resent case a lobulated mass was seen in the infratemporal fossa
ith erosion of posterolateral wall of the maxilla.
MRI  is the investigation of choice for these tumors. Usually
FH presents as a lesion with variable signal intensity, low to
ntermediate grade on T1-weighted images and intermediate to
igh on T2-weighted images. Heterogeneous signal intensities on
2-weighted and contrast-enhanced images are also a frequent
nding.2,11
Histologically the tumor contains both ﬁbroblast like and
istiocyte-like cells in varying proportions, with spindle and round
ells exhibiting a storiform arrangement. It has been divided into
our morphologic subtypes depending on the predominant cellu-
ar components: storiform-pleomorphic (50–60%), myxoid (25%),
iant cell (5–10%), and inﬂammatory (about 5%). The myxoid vari-
nt has been reported to have better prognosis when compared
ith the storiform-pleomorphic type.5,11
Wide local excision with or without radiotherapy and
hemotherapy is the mainstay of treatment.7,13 Various surgical
pproaches have been described to access tumors in the infratem-
oral fossa. A preauricular approach and its modiﬁcations are
uitable for tumors that originate in the infratemporal fossa and
ntracranial tumors that originate at the anterior aspect of the tem-
oral bone or greater wing of the sphenoid bone and that extend
nto the infratemporal fossa. However it does not provide adequate
ccess to the tympanic bone, jugular bulb or the infratemporal seg-
ent of facial nerve. The postauricular approach provides good
ccess to tumors that involve the temporal bone and that extend
nto the infratemproal fossa. The transfacial approach is best used
o resect sinonasal tumors or nasopharyngeal tumors extending to
he infratemporal fossa. Endoscopic approaches are rapidly being
eveloped and are currently used for benign tumors of sinuses and
kull bases or in some cases for palliative debulking of tumors.14In the present case a modiﬁcation of the preauricular approach
rovided good access to the tumor.
In bulky and aggressive tumors adjacent to vital structures pre-
perative chemotherapy may  be used.15,16 Radiotherapy alone mayPEN  ACCESS
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be  reserved for inoperable patients, patients with poor surgical
risks or those with regional or systemic metastasis.3 Incomplete
excision may  lead to high rate of recurrence. High local recurrence
of malignant ﬁbrous histiocytomas of bone is due to the fact that
it inﬁltrates skeletal muscle ﬁbres and fascial planes.9 In this case
present case complete excision was  achieved under frozen section
control. All margins were free of tumor.
Prognosis depends on size and site of tumor and its malignant
potential in terms of metastasis.2,7 Lungs are the most common site
of metastasis.2,17 Post-radiation sarcomas have been reported to
have poor prognosis.18 This patient however had long term disease-
free survival despite earlier exposure to radiation. Overall 5-year
survival for mandibular malignant ﬁbrous histioctyoma has been
reported to be 46% irrespective of the kind of treatment.19
Although these tumors are rare they should always be kept in
mind while diagnosing head and neck malignancies so that early
and adequate treatment may  be conferred to the patient thereby
limiting mortality and morbidity.
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